STAT3 and cancer: M Thorn et al. demonstrated that cancer cells secreting GM-SCF activate the JAK2/STAT3 signaling pathway, induce STAT3 phosphorylation in liver MDSCs and translocate to the nucleus to bind to the IDO1 and PD-L1 promoters to perform immunosuppressive functions in mouse liver [86].